Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million ≈ $5.88 Million USD) by net assets (CN¥8.71 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002019 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Grupo Mateus S.A
SA:GMAT3
0.056x
Polaris Bay Group Co Ltd
SHG:600155
0.087x
Shanghai Jahwa United Co Ltd
SHG:600315
0.020x
Zymeworks Inc. Common Stock
NASDAQ:ZYME
-0.098x
Hunan Oil Pump
SHG:603319
0.018x
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
0.048x
Kraken Robotics Inc
V:PNG
-0.046x
Guangdong Hoshion Aluminium Co Ltd
SHE:002824
0.069x

Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see 002019 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.71 Billion
≈ $1.27 Billion
CN¥458.37 Million
≈ $67.07 Million
0.053x -30.80%
2024-12-31 CN¥8.43 Billion
≈ $1.23 Billion
CN¥640.73 Million
≈ $93.76 Million
0.076x +80.06%
2023-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥348.58 Million
≈ $51.01 Million
0.042x -18.18%
2022-12-31 CN¥9.15 Billion
≈ $1.34 Billion
CN¥472.07 Million
≈ $69.08 Million
0.052x +50.34%
2021-12-31 CN¥8.78 Billion
≈ $1.28 Billion
CN¥301.23 Million
≈ $44.08 Million
0.034x -73.01%
2020-12-31 CN¥8.72 Billion
≈ $1.28 Billion
CN¥1.11 Billion
≈ $162.21 Million
0.127x +6.13%
2019-12-31 CN¥7.82 Billion
≈ $1.14 Billion
CN¥937.24 Million
≈ $137.15 Million
0.120x -29.51%
2018-12-31 CN¥6.89 Billion
≈ $1.01 Billion
CN¥1.17 Billion
≈ $171.34 Million
0.170x +1.79%
2017-12-31 CN¥6.78 Billion
≈ $992.46 Million
CN¥1.13 Billion
≈ $165.75 Million
0.167x -23.88%
2016-12-31 CN¥3.90 Billion
≈ $570.77 Million
CN¥855.85 Million
≈ $125.24 Million
0.219x +57.24%
2015-12-31 CN¥2.88 Billion
≈ $421.52 Million
CN¥401.96 Million
≈ $58.82 Million
0.140x +154.00%
2014-12-31 CN¥2.54 Billion
≈ $372.19 Million
CN¥139.74 Million
≈ $20.45 Million
0.055x -38.38%
2013-12-31 CN¥384.95 Million
≈ $56.33 Million
CN¥34.32 Million
≈ $5.02 Million
0.089x +43.45%
2012-12-31 CN¥480.81 Million
≈ $70.36 Million
CN¥29.88 Million
≈ $4.37 Million
0.062x +155.24%
2011-12-31 CN¥469.52 Million
≈ $68.71 Million
CN¥-52.82 Million
≈ $-7.73 Million
-0.113x -134.03%
2010-12-31 CN¥703.64 Million
≈ $102.96 Million
CN¥-33.82 Million
≈ $-4.95 Million
-0.048x -174.89%
2009-12-31 CN¥913.15 Million
≈ $133.62 Million
CN¥58.61 Million
≈ $8.58 Million
0.064x -56.02%
2008-12-31 CN¥570.87 Million
≈ $83.54 Million
CN¥83.31 Million
≈ $12.19 Million
0.146x -67.81%
2007-12-31 CN¥548.55 Million
≈ $80.27 Million
CN¥248.71 Million
≈ $36.39 Million
0.453x +351.02%
2006-12-31 CN¥324.46 Million
≈ $47.48 Million
CN¥32.62 Million
≈ $4.77 Million
0.101x +33.73%
2005-12-31 CN¥320.93 Million
≈ $46.96 Million
CN¥24.12 Million
≈ $3.53 Million
0.075x -30.63%
2004-12-31 CN¥309.98 Million
≈ $45.36 Million
CN¥33.59 Million
≈ $4.91 Million
0.108x -19.25%
2003-12-31 CN¥94.31 Million
≈ $13.80 Million
CN¥12.65 Million
≈ $1.85 Million
0.134x --

About Yifan Xinfu Pharmaceutical Co Ltd

SHE:002019 China Drug Manufacturers - General
Market Cap
$1.73 Billion
CN¥11.81 Billion CNY
Market Cap Rank
#6804 Global
#1513 in China
Share Price
CN¥9.71
Change (1 day)
-1.02%
52-Week Range
CN¥9.71 - CN¥16.29
All Time High
CN¥32.51
About

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more